# Evaluating the Impact of VR-therapy on BPSD and QoL of Individuals With Dementia Admitted to Hospital

> **NCT03941119** · NA · TERMINATED · sponsor: **University Health Network, Toronto** · enrollment: 77 (actual)

## Conditions studied

- Dementia
- Delirium Superimposed on Dementia

## Interventions

- **OTHER:** VR-therapy

## Key facts

- **NCT ID:** NCT03941119
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-05-06
- **Primary completion:** 2020-03-16
- **Final completion:** 2020-03-16
- **Target enrollment:** 77 (ACTUAL)
- **Why stopped:** All recruitment activities for this study (with acutely ill inpatients with dementia) stopped due to the COVID pandemic.
- **Last updated:** 2020-11-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03941119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03941119, "Evaluating the Impact of VR-therapy on BPSD and QoL of Individuals With Dementia Admitted to Hospital". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03941119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*